Skip to main content
. 2013 Aug 13;6:293–301. doi: 10.2147/DMSO.S46627

Table 1.

Initial clinical and anamnestic characteristics of patients, n (%)

Variable Patients with MI without type 2 diabetes (n=65) Patients with MI and type 2 diabetes (n=60) Control (n=30)
Men, n (%) 44 (73.3) 18 (30) 18 (60)
Age, year 61 (53;70) 66,5 (61;73,5) 58 (51;62)
Body mass index, kg/m2 25.5 (23.2;30.1) 29.65 (26.85;34.55) 23.6 (21.3;26.5)
CK MB, U/L 137.64 (99.5;165,1) 94.03 (80,3;110,3) 15.2 (11,3;19,3)
Troponin T, ng/mL 0.71 (0.36;1.02) 1.09 (0,95; 1,16) 0.09 (0.08;0.12)
Overweight, n (%) 37 (56.9) 51 (85)
Arterial hypertension, n (%) 50 (79.6) 51 (85)
Hypercholesterolemia, n (%) 25 (38.5) 27 (45)
Current smoking, n (%) 50 (79.6) 37 (61.6) 2 (6.6)
Family history of IHD, n (%) 16 (24.6) 30 (50) 5 (16)
Previous myocardial infarction, n (%) 10 (15.4) 15 (25)
Ulcerous disease, n (%) 6 (9.3) 5 (8.3)
Chronic kidney disease, n (%) 1 (2.1) 1 (1.6)
Anterior wall myocardial infarction, n (%) 45 (42) 9 (15)
Killip class I, n (%) 53 (81.5) 26 (43.3)
Killip class II–IV, n (%) 21 (35.4) 32 (53.3)
Death, n (%) 1 (0.9) 1 (1.6)

Notes: Age and body mass index and are presented as median and quartiles (Me [Q1;Q3]).

Abbreviations: CK MB, myocardial fraction of creatine phosphokinase; IHD, ischemic heart disease; MI, myocardial infaraction.